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Over the last decade, there has been a significant increase in average paternal age when the first child is
conceived, either due to increased life expectancy, widespread use of contraception, late marriages and other
factors. While the effect of maternal ageing on fertilization and reproduction is well known and several studies have
shown that women over 35 years have a higher risk of infertility, pregnancy complications, spontaneous abortion,
congenital anomalies, and perinatal complications. The effect of paternal age on semen quality and reproductive
function is controversial for several reasons. First, there is no universal definition for advanced paternal ageing.
Secondly, the literature is full of studies with conflicting results, especially for the most common parameters tested.
Advancing paternal age also has been associated with increased risk of genetic disease. Our exhaustive literature
review has demonstrated negative effects on sperm quality and testicular functions with increasing paternal age.
Epigenetics changes, DNA mutations along with chromosomal aneuploidies have been associated with increasing
paternal age. In addition to increased risk of male infertility, paternal age has also been demonstrated to impact
reproductive and fertility outcomes including a decrease in IVF/ICSI success rate and increasing rate of preterm birth.
Increasing paternal age has shown to increase the incidence of different types of disorders like autism, schizophrenia,
bipolar disorders, and childhood leukemia in the progeny. It is thereby essential to educate the infertile couples on the
disturbing links between increased paternal age and rising disorders in their offspring, to better counsel them during
their reproductive years.
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Increased life expectancy, advanced age of marriage, various
socio-economic factors and an overall change in role of
women in society has led couples to start their family at a
later age. The increased accessibility to assisted reproduct-
ive techniques has increased the chance of older parents
with poor pregnancy outcomes to conceive children, hence,
increasing the average paternal age at first childbirth. In
comparison to 1993, the paternal age of English fathers has
increased by 15% in a period of ten years [1]. Increased pa-
ternal age affects testicular function [2], reproductive hor-
mones [3], sperm parameters [4,5], sperm DNA integrity* Correspondence: agarwaa@ccf.org
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unless otherwise stated.[6], telomere length [7], de novo mutation rate [8],
chromosomal structure [6,9] and epigenetic factors [10].
These changes negatively affect fertility and reproductive
outcomes in older couples, contributing to higher
incidences of congenital birth defects [11] and fetal deaths
[12]. Increasing male age has also been shown to be
associated with numerous disorders like achondroplasia
[13], autism [14], schizophrenia and bipolar disorders,
[14] among many others. In this review article, we will
elaborate on the effects of increasing paternal age at the
molecular level as well as examine their implications on
clinical outcomes. We hope to raise awareness among
both clinicians and older couples to the risks associated
with delayed fatherhood, which may compromise their
parenthood dreams as well as their quality of life.l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Several studies in previous years have shown association
between testicular functions and advancing age [2,15-19].
Handelsman et al. reported a negative association between
increasing paternal age and reduction in testicular volume
for men >80 years [2]. They also reported a reduction
in the size of testis [17]. In a study conducted by
Mahmoud et al. it was found that compared to the
age group 18–40 years, men aged >75 years had 31%
smaller mean testicular volume. Decreased testicular
volume is attributed to the decrease in number of
Sertoli cells [15]. In addition, Johnson et al. reported
the thickening of basal membrane of seminiferous tubules
with age [16]. Disturbance in blood supply in senile
testis were associated with negative changes in terms
of hernia-like protrusions, spermiogenesis and thickness
of basement membrane [18].
Increased FSH serum levels and decreasing testosterone
levels are the most common clinically relevant alterations
associated with male ageing [20]. The decreasing tes-
tosterone levels in aging men are linked to andropau-
sal symptoms, such as poor libido, fatigue and loss of
cognitive function [21]. Both male sexual function and
sexual frequency decrease with age [22-24] and the
infertility experienced by many older men may in part
be related to the decline in sexual activity.
Leydig cells are responsible for testosterone production.
The number of Leydig cells tends to reduce with increasing
paternal age [19]. Neaves et al. reported that the average
total number of Leydig cell nuclei decrease by half in age
group of 50–76 years compared to age group of 20–48
years [19]. Reduced number of Leydig cells plays a key role
in incidence and pathogenesis of andropause in aging
men [25]. The decreased number of Leydig cells also
contribute to reduced levels of total testosterone [26]
and free testosterone (1.2%) serum levels in paternal
group >50 years.
Wu et al. reported that age-affected testicular atrophy
is a result of Hypothalamic-Pituitary-Testicular (HPT)
Axis alterations that disturb the functions of various
reproductive hormones [27]. Advanced paternal age hasTable 1 Effect of advancing paternal age on reproductive hor
Name of the hormone Levels
Dehydroepiandrosterone (DHEA) ↓
Dihydrotestosterone (DHT) No Change
Estrogen ↓
Follicle-stimulating hormone (FSH) ↑
Gonadotropin-Releasing Hormone (GnRH) ↓
Luteinizing hormone (LH) ↑
Sex hormone-binding globulin (SHBG) ↑
Testosterone ↓also been associated with changes in different hormonal
levels. Table 1 summarizes the effect of increasing paternal
age on reproductive hormones.
Sperm parameters
Semen analysis is an important first step in the laboratory
evaluation of the infertile male. It includes the assessment
of the ejaculate volume, sperm concentration, motility,
and morphology using WHO criteria [34]. Some studies
have shown that with increasing paternal age, semen
volume, sperm motility, and the percentage of normal
morphology tend to decrease [4,35].
With the introduction of the new 2010 WHO guidelines
[36], the normal reference range reported at fifth centile
has changed for many of the semen parameters. These
include: ejaculate volume from ≥2mL to 1.5 mL; sperm
concentration (from ≥20 × 106/mL to 15 × 106/mL), Total
sperm count from ≥40 × 106 to 39 × 106; percent motility
(from ≥50% to 40%); progressive motility from ≥25%
(grade a) to 32% (grade a); morphology (percent
normal forms) from 14% according to strict criteria
to 4%; vitality (% alive) from 30% to 25%; for per-
forming viability test in semen specimens with poor
motility. One of the main features of the new guide-
lines is the inclusion of the reference ranges and the
limits which are significantly lower than those reported in
the earlier manuals. It also included data from over 1900
men who recently fathered a child within one year of
trying to initiate a pregnancy. However there is much
controversy regarding the new reference values and the
impact in the management of male infertility [37]. The
American Urology association recommends that the initial
evaluation should include a reproductive history, and two
properly performed semen analysis, followed by extended
evaluation if semen parameters are abnormal in the
initial evaluation [38]. On the other hand the European
Association of Urology (EAU) recommends undertaking
male examination if the semen analysis is abnormal [39].
The impact of increasing paternal age as reflected in the
semen parameters according to the new criteria remains
to be seen and interpreted with caution.mones
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aging in males may cause changes in semen parameters
[40]. These changes can be related to seminal vesicle
inadequacy which reduces semen volume or changes
in prostate, in terms of prostate atrophy such as
reduction in water and protein content which might
affect sperm motility and ejaculate volume [40]. Kidd et al.
also reported that increasing paternal age is correlated with
decrease in ejaculate volume, sperm morphology and
motility but not with sperm concentration [40]. Comparing
two age groups (30y vs. 50y), a significant difference
was reported in semen volume (3%-22%), sperm motility
(3% - 37%) and morphology (4% - 18%) [40]. In a study
conducted by Hossain et al. it was reported that with
increasing paternal age, both sperm volume and sperm
count decreased [41]. Similarly, in a large prospective
study comprising of 3,729 male partners evaluated for
semen quality and age-specific changes, a significant
decrease was reported in sperm volume and motility
with increasing paternal age [42].
Sperm samples from 5081 men aged between 16 and
72 years were examined for effects of male age on semen
parameters [43]. Deterioration in sperm quality and
quantity after age 35 was reported with declining
probability of pregnancy following intercourse with
men >34 years old, when women age factor was eliminated
[43]. Another recent study investigated the effects of
paternal age on DNA fragmentation, semen quality
and chromosomal aneuploidies [4]. Spermatozoa from
140 infertile men between 24–76 years of age and 50
fertile men age group (25–65 years) were examined.
The findings of the study illustrated that with increased
male age, semen volume and vitality decreased while
sperm concentration and diploidy increased [4]. However,
no significant difference in the motility, morphology
and DNA fragmentation was reported with increasing
male age [4].
Similarly, in another study the correlation of men’s age
with semen quality and seminal levels of epididymal and





Effects on sperm parameters
Concentration Morphology Motility
Prospective 24-76 ↑ ↓ ↓
22-80 ↓ - ↓
22-80 - - ↓
All CASA param
of lateral head
30-50 - ↓ ↓
Retrospective 25-55 - - ↓
Prospective Not specific - Not measured ↓significant decrease in semen parameters was reported
in men aged 35 years and particularly with those over 46
years. This was associated with an increase in the
percentage of dead spermatozoa [44]. Semen samples
collected from men aged between 30 years to 40 years
showed semen parameters to be inversely related to men’s
age. Several other retrospective studies have shown a
relation between sperm parameters and age and reported
lower semen volume, lower progressive motility and
percentage of normal morphology in older men compared
to younger men [45-47].
Age threshold
As mentioned earlier, it was reported that the sperm
parameters do not change until males reach the age of
34 years [40]. In a study by Kidd et al. [40], the total
sperm count was the first parameter to be affected
immediately after a person crossed the 34 year threshold.
Sperm concentration as well as the percentage of sperm
with normal morphology declined at the age of 40. Sperm
motility and semen ejaculate volume declined at the age
of 43 years and 45 years respectively [43]. Another study
conducted in China examined the semen analysis of
20–60 years old men and showed that age was negatively
correlated with progressive motility, vitality, and percentage
of normal sperm. Rapid progressive motility and percentage
of normal sperm morphology began to decline gradually at
age 30 years, and progressive motility began to decrease at
age 40 years [48] and defective sperm function [49]. The
variation in the results of these studies could be due to the
differences in the type of study (prospective versus
retrospective) [50]. The variation of results in different
studies could be related to sexual abstinence time which
was different along with many other factors such as type
of study, different age groups, sample size and different
ethnicities, biological variability and the fact that semen
parameters are poor predictors of male fertility potential
[51,52]. A compilation of some of the recent studies and
their findings related to different sperm parameters is
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DNA fragmentation
Some of the potential causes of DNA damage in sperm
are abnormal protamination or abnormal protamines
compaction [53-55]. It is attributed to the presence of
histones (15%) that are not converted into protamines
and result in altered P1/P2 ratio in infertile men,
protamine deficiency [56-60]. Oxidative stress as a
result of increased production of reactive oxygen species or
reduced antioxidant reserves is responsible for a majority
of DNA fragmentation (almost 80%) seen as a result
of infection, inflammation or in cases of various clinical
diagnosis of male infertility [61-73]. DNA fragmentation
as a result of single or double strand breaks can be
measured by two common methods i.e. sperm chromatin
structure assay (SCSA) [74,75], or by the terminal deoxy-
nucleotidyl transferase-mediated dUTP nick end-labeling
(TUNEL) assay [76]. TUNEL assay however cannot differ-
entiate between apoptosis and necrosis.
Apoptosis in sperm is different from apoptosis seen in
somatic cells where it is regulated at the plasma level
(presence of Fas receptors), nucleus (presence of p53
inducing upregulation of Bax gene and down regulation of
Bcl-2 expression) and cytoplasm (activation of Bax and
release of cytochrome c and caspase cascade in the cytosol)
[77-79]. Ejaculated sperm show features characteristic
of apoptosis such as ultrastructural observation of the
chromatin, mitochondria, the nuclear envelope, plasma
membrane, presence of apoptotic bodies and presence of
DNA fragmentation and externalization of phosphatidyl
serine residues.
Abortive apoptosis like features in immature/abnormal
sperm include remnants of cytoplasm and poor chromatin
packaging and/or damaged DNA Abortive apoptosis is
initiated during spermatogenesis. Spermatozoa earmarked
for elimination escape at ejaculation in what is called
abortive apoptosis and contribute to poor sperm quality.
This is largely due to the presence of excess cytoplasm
present in morphologically abnormal sperm [80-82]. More
than 40% of the cells earmarked to be eliminated were
reported to be present on the seminal ejaculate as
examined by Annexin V and TUNEL assay [83].
DNA damage can also result from activated PARP and
activated caspase3. PARP-1 has been implicated in
DNA damage and apoptosis, in addition to its more
complex events such as nucleosome binding property
that promotes formation of compact, transcriptionally
repressed chromatin structures. It is also linked with
nuclear restructuring when nucleus is compacted with
the introduction of protamines. It activates apoptosis
during dramatically increased DNA repair and damage.
Cleaved PARP also provides an early marker of detecting
apoptosis as cleavage of PARP-1 occurs before DNA
fragmentation [84].DNA damage in ejaculated spermatozoa cannot be
explained by apoptosis alone [80,82]. DNA damage can also
be due to aneuploidy as well as mutations, chromosomal
disjunction and meiotic segregation [85-87].
A study conducted by Moskovtsev et al. showed that
as the incidence of semen abnormalities increased in
infertile men, the extent of DNA damage also increased
concomitantly [88]. Many other studies have reported
a positive correlation between increasing male age
and DNA damage [6,89]. Using DNA fragmentation
Index (DFI) as an index to measure DNA damage/
fragmentation, Moskovtsev et al. reported that in
comparison to age group <30, age group which was ≥ 45
had twice the DFI (15.2% vs. 32.0%). DFI levels for 30–35,
35–40 and 40–45 were found out to be 19.4%, 20.1% and
26.4% respectively [6].
Similar results were shown in a study conducted by
Singh et al. in which it was shown that the percentage of
highly damaged DNA sperm in age group 36–57 years
was significantly higher compared to the age group
20–35 years [89]. In another study involving 215 couples,
it was shown that sperm DNA damage doubled from
paternal age of 25 to 55 years [90]. A positive association
was reported between DFI and increasing paternal age
[89-91]. In a group of men with normozoospermia, the
DFI level increased by 5% in age group ≥40 compared to
age group ≤40. A similar trend was seen in a group
of men with oligoasthenoteratozoospermia in which
age group of ≥40 had 8% higher DFI levels compared
to age group ≤ 40 years [89]. Barroso et al. proposed
that the association between DNA fragmentation and
advanced paternal age is present due to sperm chromatin
defects [92].
A recent meta-analysis study comparing 26 studies
involving 10,220 subjects, the authors reported a significant
negative association of male age with DNA fragmentation
[93]. They advocate the routine screening of men with
advanced age for DNA fragmentation as well as cautioning
patients of the potential risks. Ageing male and its effect
on the functional capacity of the sperm as measured by
phosphatidyl serine expression have been reported [94].
Significantly higher expression of phosphatidyl serine
translocation at the sperm membrane indicative of
apoptosis was reported in men 40 y and older. Similarly a
trend was also reported in sperm DNA damage and
increasing age of the male.
DNA integrity and ART outcomes
Sperm DNA damage is associated within lower probability
of conception and a longer time to conception [90,95,96].
These studies suggest that DNA damage is a better
predictor of pregnancy than the conventional semen
parameters [95]. Also DNA damage is correlated with
lower pregnancy rates in intrauterine insemination and
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(ICSI) lower pregnancy rates [60,97-101]. In a recent study
by Nij’s and his group, a prospective study consisting of
278 patients who underwent intracytoplasmic sperm injec-
tion (ICSI) or in vitro fertilization (IVF) was examined for
an association between semen parameters and men’s age.
No significant influence of male age was reported on the
fertilizing capacity [102].
Positive correlations have been reported between an
increased sperm DNA fragmentation, reduced motility
and ART outcomes leading to lower pregnancy rates
and higher miscarriages [103]. Such DNA integrity
reduction was shown to be correlated to advanced
paternal age (especially for ages beyond 40 years)
[6,89], supporting the overall negative effect of ageing
fathers on IVF/ICSI success rate and hence ART out-
comes [104,105].
Sperm DNA integrity is not only important for successful
IVF but also for normal embryonic development. It has
been recently shown that the advanced paternal age and its
adverse effects on sperm DNA integrity also interfere with
early embryonic development. Morris et al. showed that
sperm DNA damage was strongly associated with
men of age 29–44 years as well as with impairment
of post-fertilization embryo cleavage [106]. In another
study of 132 ICSI patients with father’s age of >40
years, sperm DNA fragmentation was significantly affected
post-implantation during embryonic development [107]. In
a cross-sectional study of 215 infertile men who underwent
ART, Simon et al. showed that increased sperm DNA
damage negatively affected early embryonic development
and significantly reduced subsequent implantation
[108]. In study comprising of 1023 infertile couples,
Frattarelli et al. was able to show that sperm from
men >50 years led to normal embryonic early cleavage but
showed a decrease in blastocyst formation rate [109].
Two large studies have shown that paternal aging is
associated with increased risk of pregnancy loss after an
established pregnancy by IUI suggesting that advanced
paternal age may affect genomic integrity and thereby
negatively impact the embryo development [60,110].
A lack of consistent significant association between
paternal age and sperm concentration as well as lack
of association between paternal age and IVF or ICSI
pregnancy rates [60,110-113].
Contrary to this another meta-analysis report consisting
of 7 IVF and IVF/ICSI studies reported no association of
paternal age with pregnancy loss after an established
pregnancy [113]. This could possibly be due to the
fact that the natural and IUI pregnancy in these studies
were from men with relatively homogenous and normal
semen parameters whereas those in IVF/ ICSI were from
a heterogeneous population of men and this may have
diluted the effect of age.In conclusion, advanced paternal age increases the DNA
fragmentation in sperm negatively affecting the IVF/ICSI
success rates, ART outcomes as well as early embryo
development. Despite increasing evidence of positive
correlation between sperm DNA fragmentation and
reduced male infertility, the ASRM guidelines does
not support the routine use of sperm DNA integrity
assessment in clinical practice [100]. However, they
recommend further confirmation of sperm DNA integrity
test using randomized studies and a high number of
patients.
Telomere length
Telomeres are tandemly repeated hexameric nucleotide
repeat sequences (TTAGGG). Telomeres cap the ends of
eukaryotic chromosomes. Their primary role is to
preserve genomic structure and maintain its stability
[114]. With each successive cell division, and hence with
aging, the telomere length in somatic cells undergoes
progressive shortening [115-119]. The somatic cells, for
years were represented by leukocytes, but in a recent
study conducted by Daniali et al. [120] four different
somatic cells (leukocyte, muscle, skin and fat cells) were
used to measure the association between telomere length
and increasing age [120]. Like leukocytes, three other
somatic cells’ telomere length was also found to decrease
with increasing age [120]. In somatic cells, the guanine
rich repetitive telomere DNA is maintained by telomerase,
a reverse transcriptase enzyme [121]. With each cell
division, some telomere repeats are not copied and hence
are lost. But telomerase extends telomere by adding
TTAGGG repeats. With increasing age, the incomplete
DNA replication leads to telomere shortening [121].
When telomere length reaches a critical length, the cell
cannot divide and the cell enters cell-cycle arrest or
undergoes apoptosis. Telomere length is maintained
by telomerase that is maximally expressed in highly
proliferative cells such as germ cells and neoplastic
cells [122,123]. A strong positive correlation has been
reported between paternal age at birth and offspring
LTL [124-129].
It has been reported that increased Leukocyte
Telomere Length (LTL) is associated with reduced
risk of atherosclerosis and hence, increased survival.
Since increased paternal age increases LTL, it is a
possibility that offspring of relatively old fathers have
reduced risk of atherosclerosis and increased survival
[130]. Consequently, increased LTL can also increase the
risk of breast cancer in daughters of old fathers since it
has been reported that there is a correlation between
increased LTL and increased breast cancer risk [128].
Interestingly and compared to somatic cells, sperm
(germ cell) telomere length was found to increase
with increasing age [127,131,132]. Although such rare
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and poorly understood, it might be explained as kind
of a biological resistance against the aging process.
This molecular resistance expressed by human species
against aging might be necessary to boost the chances
of perpetuation of the species’. Further studies are required
to confirm this discrepancy of telomerase extension
observed in testis. In fact, it has been reported that
average telomere length is heritable and can be passed
down to offspring [126]. Interestingly, the effects of
paternal age on telomere lengths have also been noticed
in offspring [133]. It has been shown that telomere length
inheritance is mainly determined by an offspring’s father
[134]. A meta-analysis comprising 19,000 participants was
conducted by Broer et al. [7]. These investigators analyzed
six studies where they randomly examined telomere
length and its heritability. A negative association was
reported between telomere length and the age [7]. A
significant correlation was also seen between advanced
male age and telomere length, though maternal age played
a more significant role [7].
In offspring both sperm [133] and leukocyte telomere
length increases with increasing paternal age [129,130,133].
The role of sperm telomeres and telomere length is still
unclear. Although both leukocyte telomere length
(LTL) and sperm telomere length (STL) correlate
within the same individual, LTL decreases whereas STL
increases with age [127,131,132,135]. This is more likely
related to the increased activity of reverse transcriptase
activity - the catalytic unit of telomerase [136,137]. High
reverse transcriptase activity in germ cells or cellular
attrition resulting in death of stem cells with shortened
telomere length results in selection of sperm with longer
telomeres [127,133].
The role of STL in spermatogenesis or fertility potential
is unclear. A recent report examined a group of healthy
18–19 years old subjects and compared telomere length
and sperm, spermatogenic activity and the age of the
parents at birth [132]. They showed a positive correlation
between STL and sperm count and significantly shorter
STL in men with oligozoospermia when compared to
those with normozoospermia. They also showed effect of
parental age on offspring STL [132]. In another study,
STL in men with idiopathic infertility and controls was
examined and a shorter telomere length was reported in
men with unexplained male infertility [138]. Although
there were differences in these two studies mainly, in the
study by Thilagavathi et al., LTL was not considered and
included low number of subjects with unknown age and
normal mean sperm count, sample size was small com-
pared to the study by Ferlin et al. It is clear that telomeres
play an important role in meiosis and thereby maintain
genomic integrity [139]; shorter telomere suggested
impaired spermatogenesis through segregation errorsas telomerase activity peaks in the testis in meiosis I
primary spermatocytes [139]. Shorter telomeres can be
regarded as putative cause of impaired spermatogenesis
and male infertility, although additional studies are needed
to verify this interpretation. Shorter telomeres in ejaculated
sperm may be a marker of damaged spermatogenesis
and a consequence rather than a cause of altered
spermatogenesis. Shorter telomere length in oligozoosper-
mic men as reported by Thilagavathi et al. has implica-
tions in assisted reproductive techniques as the offspring
will inherit smaller [138]. However additional studies are
need to verify the pathophysiological link between STL
and damaged spermatogenesis as well as its effect on the
offspring telomere length especially in older couples
where the man is oligozoospermic.
DNA mutations
In contrast to oogenesis, sperms divide (or spermatogenesis
occurs) continuously throughout reproductive lifetime
and hence accumulates greater number of cell divisions.
Spermatozoa a can also acquire de novo single nucleotide
variants or mutations because of the continuous ongoing
process of spermatogenesis that involves multiple
asymmetric pre-meiotic spermatogonial divisions and the
testicular environment is more prone to toxic effects of
oxidative stress in ageing men [8]. Furthermore errors on
post-meiotic remodeling of chromatin remodeling and
DNA repair cam also result in de novo mutations [140].
Spermatozoa from aging fathers can also be more prone to
chromosomal aneuploidy [141]. The paternal contribution
to offspring novo mutations was estimated to increase by
4% per year [142]. At the age of 20, a sperm would have
undergone 150 chromosomal replications, and at the age
of 50, it would have gone through 840 replications
[8,143,144]. This increases the probability of replication
errors in the germ line leading to the accumulation
of mutations and hence increased de novo mutation
rate in spermatozoa [142]. This problem is further
aggravated when age-sensitive processes such as DNA
replication and repair are compromised due to an
increasing age [8]. Kong et al. and his team reported
the positive association between the age and de novo
mutation rate [142]. On average, the rate of de novo
mutation increases by two base pairs every successive
year [142]. Kong et al. also reported that the heritability of
mutations in an offspring is mainly attributed to paternal
age [142]. This increases the probability of older fathers
conceiving fetuses with rare and harmful disorders [145].
Paternal Age Effect (PAE) disorders are a small number of
rare disorders which occurs due to specific mutations in
fibroblastic growth factor receptor (FGFR) [146-148].
Wyrobek et al. found that sperm of men with age of
22–80 years associated with mutation in FGFR3 in
particular and this was also associated with achondroplasia
Table 3 Effects of paternal age on some of the
chromosomal aneuploidies
Type of chromosomal aneuploidy Relative risk Reference
Trisomy 21 ↑ [160]
Trisomy 18 Mixed [161-163]
Trisomy 13 Mixed [161]
Trisomy 16 No affect [164]
Trisomy 15 No affect [165,166]
47,XXY Mixed [167]
45, X Mixed [168]
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sources of mutations found in human species [8]. Though
this phenomenon aids in the diversification of the species,
unfortunately, it can also increase the incidence of rare
disorders in the human population.
A chromosomal anomaly such as Klinefelter syndrome,
47, XXY is carried by 5% of all infertile men and microde-
letions of the long arm of the Y chromosome are present in
10% of azoospermic or severely oligozoospermic men
[150]. It has been shown that the post-meiotic events
during spermiogenesis are critical from which de novo
genetic mutation could be induced [140]. A number of
mechanisms have been suggested to explain the induction
of these de novo mutations. Among these is a base substi-
tution due to the nucleotides are not incorporated by the
polymerase [151], and insertion or deletion which could
lead to a high rate of cell divisions and subsequent de novo
mutation [152]. It is interesting to mention that the
frequency and the increase in a de novo chromatin
translocation detected in 10 sperm donors was found
to be not an age dependant [153] suggesting a replicate-
independent mechanism for formation of the transloca-
tions. NRA51 nuclear receptor also called the steroidogenic
factor 1 is a key transcriptional regulator of genes.
Mutations of NRE5-1 have been reported in 46,XY
disorders of sex development and in 46,XX primary
ovarian insufficiency in 4% of men with otherwise
unexplained severe spermatogenic failure [154]. Some
forms of male factor may be an indicator of testicular
dysgenesis which requires careful clinical investigation
of men presenting with infertility and inconsistent
testosterone and gonadotropin levels. De novo point
mutation in the Y-chromosomal gene USP9Y has been
reported in a man with non-obstructive azoospermia,
causing spermatogenic failure [155]. Similarly these
authors also reported a single-gene deletion that was
associated with spermatogenic failure.
Chromosomal aneuploidies
Chromosomal aneuploidy is the presence of an abnormal
number of chromosomes in a cell. Chromosomal
aneuploidy is caused in a sperm when it undergoes
meiosis but the chromosomes are not equally divided
in daughter cells because of disjunction. Most of the
aneuploid embryos die in-utero and hence chromosomal
aneuploidy is the leading cause of failed pregnancy [156].
However, 1% of aneuploid pregnancies lead to live birth
[156] which accounts for a large number of congenital
birth defects and/ or mental retardation [157].
On average, 10% of sperm cells of healthy male popu-
lation have chromosomal aneuploidies and include
chromosome 21 and 22 [158]. However, this number
increases with paternal age [159]. The incidence of sex
chromosome disomy 18 significantly increases amongolder men (>50 years) when compared to younger men
[159]. McIntosh et al. reported increased risk of up to
two fold among fathers of 50 years and older when
compared to the fathers of age group 25–29 years
[160]. Table 3 summarizes the effect of paternal age
on chromosomal aneuploidies.
Molecular aging and genomic instability
Aging is a multifactorial and complex process leading to
progressive impaired cellular functions and hence
increased vulnerability to diseases [169]. Aging affects
several processes including DNA damage [170], telomere
shortening [171,172] leading to cellular senescence or
apoptosis [172] (Figure 1). In this context, advanced
paternal age would lead to the accumulation of de novo
mutations, male infertility and increased genetic risks on
the offspring e.g. autism and schizophrenia [142,173].
The dysfunctional telomerase was reported to induce
DNA-damage response in senescence phase [174].
Genomic instability at the cellular level will lead to
variation at the gene expression level and affect
microRNA (miRNA) patterns with aging [172,175,176].
miRNAs are non-coding RNAs consisting of small RNAs
(~22 nucleotides) and are critical regulators of post-
transcriptional gene expression by targeting mRNAs for
cleavage or translational repression. These miRNAs have
been identified in the seminal plasma as potential markers
of male infertility and their expression patterns change
with age or other stress factors as vasectomy [177,178].
Therefore, more work is needed at this level to enhance
our comprehension of the gene players controlling normal
versus abnormal sperm development, differentiation
and maturation in both adult and aged cases. The
final differentiation and maturation of spermatozoa
occur in the epididymis where the coiled mass of tubes
play crucial role in carrying, storage and maturation of
sperm [179,180]. Zhang et al. carried out comparative
expression pattern analysis of microRNAs in epididymis of
newborn, adults (aged 25 years) and aged (aged 75 years).
The analysis revealed that a total number of 251 miRNAs
expressed in newborn epididymis (represents 63% of the
Figure 1 Main factors involved in impaired male infertility due to reproductive aging.
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[181]. The mechanism through which this change in
miRNAs expression affects the sperm quality and DNA
integrity is to be yet investigated.
Epigenetics of male aging
Epigenetics is stable heritable modification on histone
tails but not the DNA sequence that leads to altered
gene expression [182]. Unlike DNA mutations, epigenetic
patterns can be disrupted or silenced by various environ-
mental and endogenous factors such as nutrition, age,
drug/toxin exposure and phenotypic variation. Therefore,
both spermatogenesis and spermiogenesis processes are
marked by successive steps of epigenetic reprogramming of
the male gamete which is influenced by several environ-
mental factors (Figure 1). These epigenetic events may
impair or inhibit key steps of fertilization, implantation
and/or the embryo development [183]. Loss of methylation
at the paternally imprinted H19-DMR (differentially
methylated region) locus was reported in sperm of
men with unexplained low sperm counts [184]. On
further investigation revealed abnormalities in 14% to
20% of men with moderate or severe oligozoospermia
[185-188]. Genome wide analysis suggested global
hyper methylation of DNA from poor quality sperm,
pointing to the poor improper erasure of DNA methyla-
tion during germ cell development [189]. Epigenetic
modifications in the sperm selected for ART can also leadto perturbations or increase the imprinted congenital
phenotype because of the ART technique itself.
Methylation profile of two imprinted loci H19-DMR
and PEG 1/MEST-DMR have been studied in men
showing phenotypes ranging from severe oligozoospermia
to normospermia. The methylation profile of these two
loci was used as a marker of sperm DNA methylation
status by Montjean et al. [190]. They found epimethylation
and epimutations in 20% in H19-DMR and 3% in PEG 1/
MEST-DMR of spermatozoa of oligozoospermic men but
did not observe an association with the genetic variants or
in the ART outcome.
It has been reported that in addition to the age, the
role of father’s nutrition and his exposure to toxicants is
so strong that not only affects his offspring’s epigenetic
factors but also his grand-offspring epigenetics factors as
well [10]. However, a study conducted by Benchaib et al.
reported that there is no correlation between DNA
methylation and paternal age [191,192]. This study proves
that some of the epigenetic factors are not only heritable
but also stable.
DNA methylation and repressive histone modification
are two of the most common mechanisms which cause
gene silencing. It has been found that DNA methylation
plays an important role in mammalian development and
influences different processes like X-inactivation [193],
genomic imprinting and embryo development as soon as
the zygote is formed [194].
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in embryo development, Benchaib et al. [192] conducted a
prospective study to assess the influence of global sperm
DNA methylation on IVF outcomes. They demonstrated
that pregnancy outcomes were significantly improved in
sperm with global methylation level (GML) higher than
arbitrary threshold value (555 AU). However, others
reported no change in fertilization rates and quality
of embryos [191,192]. These investigators suggested that
germ line which has been epigenetically reprogrammed
might lead to compromised spermatogenesis and
eventually result in infertility. Ace-1(Ace-variant1), Prm1
(Protamine 1), Prm2 (Protamine 2) and Smcp (Sperm
mitochondrial-associated cysteine-rich protein) are key
sperm genes which are known to bind to chromatin. A
recent longitudinal study conducted on mice reported that
expression levels of Ace-1, Prm1, Prm2 and Smcp genes
which are genetically regulated by epigenetic factors
were shown to decrease with increasing paternal age.
During spermiogenesis, these proteins replace most of
the canonical histones [194]. Decreased expression levels
of Prm1 Prm2, Smcp result in decreased semen quality
and IVF pregnancy rates [195].
Furthermore, the levels of 5-mc and 5-hmc (methylated
forms of cytosine) increased (by 1.76% every year) with a
concomitant increase in paternal age in donors which in
turn causes gene silencing [196]. Angelman Syndrome is a
neurogenetic disorder associated with both developmental
and intellectual disability [197] while Bechwith-Wiedmann
Syndome is a genetic disorder which is usually associated
with overgrowth and increased risk of childhood cancer
[198]. Gosden et al. reported that incidence of rare disor-
ders like Angelman syndrome and Beckwith-Wiedemann
syndrome increased significantly in babies conceived with
different assistive reproductive techniques, suggesting that
the result is possibly because relatively old couples opt for
assisted reproductive technology (ART) techniques for
conception [199].
Paternal Age Effect (PAE) disorders
The correlation between increasing paternal age and
genetic defects was first suggested in late 1800s by
Weinburg [200] while the association between increasing
paternal age and genetic disorder such as Achondroplasia
was found by Penrose in 1955 [201]. Ever since, many
other genetic disorders have been associated to increasing
paternal age. An increase in de novo mutation rate has
been reported as the major cause of paternal age effect
disorders (Figure 1). Most of the mutations detected in
disorders associated with increasing paternal age are single
base pair substitutions [202]. In a study conducted by
Kong et al. using deep sequencing analysis, they reported
that with increasing paternal age, the germ line single base
pair substitutions increased at the rate of 2 base pairs peryear [142]. Realizing the significance of paternal age disor-
ders in male, the British Andrology Society and American
Society for Reproductive Medicine set the upper age limit
for sperm donors at 40 years [203,204].
In this section we will highlight some of the genetic dis-
orders which are associated with advancing paternal age.
Schizophrenia
Advanced paternal age has been associated with schizo-
phrenia in many studies [14,205-208]. Schizophrenia is a
psychiatric disorder which is associated with disabilities
in social and occupational functioning. It also involves
recurrent or chronic psychosis [209]. Schizophrenia is
not only lethal in terms of the disability caused to a
victim, but also an economically burdening disorder.
It has been ranked by WHO as one of the top ten
diseases contributing to global burden of diseases
[210]. Schizophrenia is an etiologically heterogeneous
syndrome and has a strong genetic influence [211,212].
The genetic influence is so strong that a quarter of
all cases of schizophrenia are attributed to increasing
paternal age [213].
In a cohort study comprising of 754,330 Swedish
subjects, it was reported that with every 10 year increase
in paternal age at the time of conception, the risk of an
offspring having schizophrenia increased by 1.47 times.
Interestingly, offspring with younger fathers (<21 years)
were also at a higher risk of schizophrenia compared to
the fathers aged 21-24years at the time of conception
[206]. In a meta-analysis conducted by Miller et al.
comprising of 12 cohort and case–control studies, the
offsprings of older fathers (>30 years) had higher risks of
schizophrenia compared to reference paternal age of
25–29 years. Similar to the result of Swedish cohort
study mentioned earlier, Miller et al. also showed that
younger fathers (<25 years old) had higher risk (Relative
Risk ratio = 1.08, 95% CI: 1.02–1.14, P = 0.01) compared to
the age group of 25–29 years old fathers [207].
To further investigate whether socially and culturally
different countries showed similar association between
advanced paternal age and schizophrenia, Tsuchiya et al.
and his team conducted a study in Japan and reported a
similar association [214]. Wohl et al. conducted a study
to compare the effect of different paternal age groups on
risk factor of schizophrenia in offsprings. The odds ratio
for fathers’ age increased exponentially from 1.16 in age
group 25–34 years to 5.92 in fathers over the age of 55
years [215].
Frans et al. conducted a national register-based cohort
study which involved 120,758 individuals to examine
whether grandparent’s age contributed to the grand off-
spring’s risk of having schizophrenia. It was observed that
old grandmother’s age increased the risk of schizophrenia
in grandchild but not grandfather’s age [208].
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age and schizophrenia is mainly due to the accumulation of
de novo mutations in sperm [206,208,211,212]. Although a
number of studies have supported the mechanism of de
novo mutations as a causative factor for the occurrence of
Schizophrenia, other mechanisms may play a role. For
example, when the age of a father was adjusted for
first fatherhood, no association was found between
increased paternal age and increased risk [216].
Dysregulation of epigenetics at the DNA methylation,
histone modifications or chromatin remodelling level,
with respect to increasing paternal age could also
increase the risk of Schizophrenia. Genomic imprinting
also known as parental imprinting is a phenomenon in
which a gene is expressed in a parent of origin-specific
manner [217]. Alterations in epigenetic mechanisms like
parental imprinting can also have negative implications on
the offspring [218].
Bipolar disorder
Bipolar Disorder (BPD) is a heterogeneous brain disorder
associated with severe mood swings. Many studies have
shown significant association between risk factors of BPD
in offspring’s with increased paternal age [14,219,220].
A population based registry study involving 7, 328,
and 100 individuals conducted by Frans et al. found out
that the risk for BPD in offsprings increased with
increased paternal age [219]. In comparison to offsprings
of fathers aged 20–24 (control group), the offsprings of
fathers aged 55 and older had 1.34 times higher risk of
being diagnosed with BPD [219]. Offspring’s whose fathers
were <20 years old at the time of their birth had 2.63 times
higher risk of being diagnosed with BPD [219]. The rea-
sons behind increased risk of BPD in younger population
can be due to immature sperm, stressful environment,
smoking and even alcohol abuse. Also, younger fathers are
likely to come from disadvantaged background, which can
contribute to poor postnatal care [209]. Menezes et al.
showed that with increase of every ten years in paternal
age, the risk factor for BPD in offspring increased by 1.20
times after adjusting for maternal age [220].
In a recent population-based cohort study which involved
2,615,081 individuals from Sweden, it was reported that
increased paternal age was associated with increased risk of
bipolar disorder. The offsprings born to parents >45 years
old had increased hazard ratio (or relative risk ratio) of 24.7
compared to off springs born to parents 20–24 years old
[14]. In contrast, Buizer-Voskamp et al. did not find
any association between advanced paternal age and
increased risk factor of BPD [205].
Similar to schizophrenia and other mental disorders
associated with increasing paternal age, BPD might
possibly result from de novo mutations which are caused
by DNA copy errors. Epigenetics might also play role incausing paternal age effect disorders, [209,221]. Kaminsky
et al. [222] reported that compared to the control group,
the DNA methylation of human leukocyte antigen [223]
complex group 9 gene (HCG9) increased in BPD patients.
This might explain the possible mechanism of the
occurrence of increased risk factor for BPD for offsprings
with advanced paternal age since, DNA methylation
increases with advanced paternal age.
Autism
Autism spectrum disorder refers to a group of complex
disorders which are characterized by difficulties in
verbal and nonverbal communications, interaction with
people and tendency to display repetitive behaviours
[224]. Autism is usually diagnosed in children at an early
age of 3 years [225].
Many studies have shown that there is a significant
association between increased paternal age and the risk
of autism [14,205,226-229]. In a recent registry study
conducted by Buizer-Voskamp and his group, it was
calculated that in comparison to younger fathers (<20y),
older fathers (>45y) had 3.3 times higher risk of conceiving
an offspring with autism [205]. Similarly, Reichenberg et al.
[226] reported that compared to offspring’s of parents who
were <30 years old, the offspring’s of parents >50 years had
5.75 higher risk of having autism. Another study per-
formed on Icelandic population concluded a statistically
significant correlation between increasing paternal age
and autism [142]. In a meta-analysis conducted by
Hultman et al. it was found that the risk of autism in
offspring increased with advanced paternal age [227].
Compared to reference age group (<29y), the risk of autism
increased two fold in offsprings of age group >50 years,
while controlling maternal age and other risk factors [227].
Interestingly, a significant association was also found
between advanced grandpaternal age at the time a parent
was born and the risk of autism in grandchildren. An
offspring would have 1.79 times increased chance of
having autism if his/her maternal grandfather gave birth
to his/her mother when he was over the age of 50 years.
For an offspring with paternal grandfather, the risk is
reduced to 1.67 times but it is still significantly higher
[182,230]. Using an animal model, a similar association was
found in mouse which displayed decreased sociability, in-
creased grooming activity, increased ultrasound vocalization
(USV) activity and increased anxiety-like responses in
offsprings of grandfather who gave birth to their parents
at an older age [231].
It is believed that one of the causative factors of
autism is mutation of transcription factors which play
dominant role in gene expression [224]. As discussed
earlier, epigenetic factors have a very high heritability
and this might explain the reason why higher risk of
autism is found across the generations. Some studies have
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germ contribute to increased risk of neurodevelopmental
disorders like autism [232,233].
Other disorders
We have discussed the effect of paternal age on different
neurocognitive disorders. Other specific conditions ran-
ging from autosomal disorders such as Achondroplasia
and Apert Syndrome to various congenital anomalies like
Klinefelter syndrome have been associated with increasing
paternal age. Some of the most common disorders associ-
ated with advanced paternal age are shown in Table 4.
Reproductive and fertility outcomes
Advanced paternal age and time to pregnancy/male
fecundity
Fecundity is defined as the likelihood of achieving a
pregnancy in a defined period of time. Using time to
conception as an index to measure male fecundity,
Ford et al. [250] reported that there is a significant
decline in male fecundity with advanced paternal age
after adjusting maternal age and other confounding
factors. For men older than 40 years, the odds ratios
for conception in <12 months were 0.62 for 30–34
years old, 0.50 for 35–39 years old and 0.51 compared to
the reference age group (<25 y) [250]. However, one of the
limitations of this study was that it was unable to de-
termine whether the male fecundity reduced solely
because of the biological changes in male reproductive
system or because of reduced coital frequency, which is
also associated with increasing paternal age [21-24].
Association of paternal age with fertility is contradictory.
This may be attributed to the decline in male sexual
activity as frequency of intercourse decreases with age.
The general consensus is that paternal age is associated
with reduced fertility especially in couples where men are
older than 40 years and age of the women is at least 35
years [251,252]. To find the effect of biological changes in
failure to conceive, de La Rochebrochard et al. [204]
conducted a study to find the association between
advanced paternal age and the risk of failure to conceive
after IVF attempts. They reported that the odds ratio of
1.70 for paternal age of 40 years and older compared to 30
years and younger, showing significant increase in failure
to conceive [204]. When maternal age was involved, the
odds ratio increased to 2.00 for men >40 years when the
woman was 35–37 years and the odds ratio increased
exponentially for same paternal age when the maternal
age increased to >41 years [204].
In a similar study conducted by Hassan et al. it was
reported that compared to men who were <25 years,
older men who were >45 years had 4.5 times and 12.5
times increasing risk of having Time to Pregnancy (TTP)
of >1 years and >2 years respectively [253]. Dunson et al.also reported significantly reduced fertility in men >35
years [254].
Paternal age, intrauterine insemination success and live
birth rates
Reports have shown a decrease in assisted pregnancy rate
with increasing paternal age, [255-257]. Mathieu et al.
reported that male age ≥ 35y was associated with decreased
clinical pregnancy rate [255]. Belloc et al. reported that
significant decline in artificial conception rate when
pregnancy rate decreased from 12.3% per cycle in
men aged <30 to 9.3% in men ≥45 years Belloc et al.
[256]. Similar findings were reported by Demir et al. [257].
In a prospective study conducted by Klonoff-Cohen et al.
it was reported that with increasing paternal age, the
live birth rate decreased, showing a decrease in artificial
pregnancy rate [258].
Spontaneous abortions
Spontaneous abortion is defined as loss of pregnancy
occurring before 20 weeks of gestation [158]. It is seen
in 10-15% of clinically recognized pregnancies [259].
Increasing paternal age is significantly associated with
the risk of spontaneous abortions [260]. In a retrospective
study, de la Rochebrochard and her colleagues [260]
reported that compared with 20–29 years age group
(both paternal and maternal), the odds ratio of risk of
having miscarriage increased to 1.06, 1.31 and 1.80
when the paternal age increased from 30–34 years,
35–39 years and 40–64 respectively while the maternal
age remained unchanged at 20–29 years. Similarly in
another study, the odds ratio increased by 1.2, 1.5
and 1.3 for age groups 30-34y, 35-39y and >40 years
old respectively, after adjusting for maternal age [261].
Slama et al. reported that subjects in >35 years group had
increased risk of 1.27 times compared to <35 years age
group [262]. In a recent French study, Belloc et al.
reported an increase in miscarriage rate to 32.4% in
fathers ≥45 years compared to 13.7% in the fathers
who were <30 years [256]. However, not all studies
showed similar results [113,258,263,264].
Pre-eclampsia and advanced paternal age
Pre-eclampsia refers to the onset of hypertension and
either proteinuria or end-organ dysfunction after 20
weeks of gestation in a previously normotensive woman
[265]. Harlap et al. reported a significant association
between increasing paternal age and preeclampsia
[266]. These authors observed an increase in the odds
ratio in 35-39y, 45-49y and 50-54y paternal age groups by
1.30, 1.89 and 1.54 respectively, compared to the 25-29y
paternal age group and this was independent of maternal
age [266,267].
Table 4 Effect of paternal age on various disorders showing effect of age and relative risk ratio
Type of disorder Disorder Age (Reference age) Relative risk Reference
Neuro-cognitive Autism >45(<20) 3.3 [205]
>50(<30) 5.75 [226]
>50(<29) 2.2 [142,227]
Bipolar disorder >55(20–24) 1.34 [219]
Not specified 1.20 [220]
>45(20–24) 24.7 (Hazard Ratio) [14,206]
Schizophrenia Not specified 1.47 [207]
Autosomal dominant >50(25–29) 1.66 [214,215]
>32(<28) 3.00 [13]
>55(25) 5.92 [211,213,216]
Achondroplasia >30(<30) 3.48 [234]
>50(25–29) 7.80 [236]
Apert syndrome - - [235-237]
Neurofibromatosis I >35 (<35) 1.69 [238]
>40(<30) 2.9 [239]
Osteogenesis imperfecta 22-80 1.37 [13]
>35(<35) 1.62 [240]
>35(<25) - -
Retinoblastoma >35(Not specified) 1.73 [241]
>45 3.00 [242]
Congenital Abnormalities Cleft Lips Not specified [243]
Anencephaly >40 [11]
Transposition of Great Vessels >45 > 40 1.27 [11]
1.20
Ventricular Septal Defects >35 3.63 [160]
30–34 1.69
(25–29)










MSA >35(30–34) 1.33 [246]
Tracheoesophageal fistula 30-34(<25) 2.55 [247]
- 3.12 [248]
- 1.34 [248]
Others OCD >40 1.14 [248]
Childhood CNS Tumor >35-39 1.11 [248]
(25–29)
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Table 4 Effect of paternal age on various disorders showing effect of age and relative risk ratio (Continued)
Childhood Leukemia >35-39 1.29 [248]
(25–29)
Mood disorder >35-39 1.07 [249]
(25–29)
Personality disorder – - [249]
Mental retardation - - [249]
Pervasive developmental disorders - - [249]
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paternal age
Pre-term delivery is defined by the occurrence of delivery
before the completion of 37 weeks of gestation [268]. Pre-
term birth is responsible for causing 27% neonatal deaths
worldwide, leading to over a million deaths annually [269].
It is also associated with more than 70% of early life mor-
bidity and mortality, making it one of the largest health
problems in reproductive health [270]. Zhu et al. reported
that with increasing paternal age, the risk of preterm
births increased [271]. Compared with the reference age
group 20–24 years, paternal age groups 25-29y, 35-39y,
40-44y, 45-49y and >50y showed increased odds ratio of
1.3, 1.4, 1.7, 1.6 and 2.1 respectively for pre-term birth
[271]. Astolfi et al. reported that the odds ratio for
preterm increased with increasing paternal age. They
reported that father’s age group had increased odds
ratio of 1.91 and 1.71 when adjusted for maternal age
of 20–24 and 25–29 respectively [272]. However, some
of the previously conducted studies did not find any
significant association between paternal age and increased
risk of pre-term, [273-276].
Low birth weight is a leading cause of infant mortality
in the United States. It is associated with attention
deficit hyperactivity disorder (ADHD), blindness, epilepsy,
chronic lung disease, cerebral palsy, all of them leading to
long term health problems [277]. Alio et al. reported that
in comparison to the paternal age group of 25–29 years,
age group >45 years had 19% increased likelihood of
low birth weight and 13% increased risk of preterm
(between 33 and 37 weeks of gestation) birth [12]. In
another study, Reichman et al. conducted a cohort study
in which they concluded that fathers aged ≥35y had 1.9
times increased risk of conceiving low-birth weight
offspring compared to 20-34y group [9].
Still-birth/ fetal death and increasing paternal age
Still-birth defines a fetal death that occurs prior to the
expulsion from its mother [278]. Alio et al. conducted a
study where the paternal age group >45 years had 48%
increased risk of still-birth (utero-fetal death ≥28 weeks)
compared to the 25–29 years group [12]. In a cohort
study conducted by Nybo et al. it was found out thatthe pregnancies fathered by men aged 45–49 y had
an increased risk of late fetal death (>20 weeks of
gestation) with an odds ratio of 1.40 when adjusted
for maternal age [279].
For pregnancies fathered by men aged ≥ 50 years, both
the risks for early fetal death (≤20 weeks of gestation)
and late fetal death increased with the hazard ratio of
1.38 and 3.94 respectively [279]. Alio et al. reported that
in comparison to the paternal age group of 25–29 years,
age group >45 years had 22% increased risk of stillbirth
[12]. Similarly, Astolfi et al. reported that father’s
aged ≥ 40y contributed to increase stillbirth risk compared
to fathers in younger age groups [280].
Genome-wide association studies and male
reproductive aging
The post-genomic area is marked by the development of
cutting edge technologies that allowed a wide screening
of the whole human genome at once. These genome-wide
association studies (GWAS) have been widely used to
study complex traits and to identify key genomic regions
associated to several diseases. In this context, more than
1000 male infertility-associated genes have been already
reported [281]. However, the transcriptomic, genomic and
epigenomic behavior of these genes as well as many
single-nucleotide polymorphisms (SNP) during the male
reproductive aging is still unknown. A gene discovery
approach based on hybridization/ microarrays technolo-
gies and followed by specific target identification using
high throughput sequencing are required to further our
comprehension of the molecular mechanism and signaling
pathways underlying the male reproductive function in
general and specifically the aging process [282]. A suitable
choice of the type of tissues/fluids, the stage, and the
factors to be investigated are also key elements to be
considered (Figure 1), [283-285].
The GWAS technique has the potential to unravel many
genetic disorders through the analysis (sequencing) of
the DNA, RNA, miRNA, SNPs, copy number variations
(CNVs), insertions/deletions and other genomic parame-
ters related to male infertility and aging, [105,145,286].
However, such studies require a proper experimental
design and enough number of patients with comparable
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the samples and the various aging effects to be assessed
[169]. These suggested data are required to set up func-
tional validation [281] to demystify the role of each target
genes and understand the molecular process of male infer-
tility in its entirety, at a particular stage and over time.
Conclusions and future directions
Several studies have demonstrated the effects of increasing
paternal age on various molecular mechanisms such as
DNA mutations, chromosomal aberrations and epigenetic
patterns. This molecular aging process was shown to
induce changes in reproductive hormones’ profiles,
decrease sperm quality parameters and contribute to
male infertility. These alterations are also responsible
for various types of congenital disorders and pregnancy
outcomes such as spontaneous abortions and preterm
births. Although a number of studies have been conducted
to assess the negative effects involved with increasing
paternal age, the molecular mechanisms which cause
the effects are still poorly understood. It is proposed
that further research should be conducted to demystify
the mechanisms involved. The use of cutting-edge
technologies mainly next-generation sequencing to
study the relationship between aging and male infertility
will build a framework for future studies on the molecular
reproductive aging in order to design advanced male infer-
tility diagnostic and therapeutic tools to delay the aging
aforementioned negative effect. The identification of
aging versus longevity-related genes will also help to
predict the age impact on the reproductive function.
Furthermore, it will be possible to accurately establish an
‘Age Threshold’which once crossed; a prospective father
should attend a counselling session in which he should
be educated about the risks involved with conceiving an
offspring at old age.
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